Insights: Events Intellectual Property Strategies for Therapeutic Antibodies

21st International Conference on Human Antibodies & Hybridomas

The 21st International Conference on Human Antibodies & Hybridomas scientific program will have a broadened scope from previous events with the addition of some new topic areas outlined in the scope section below. As usual the scientific program will include keynote lectures, contributed oral papers and poster presentations emphasizing all key aspects of human antibody technologies, applications and engineering.

The scope of the HAH 2018 conference falls broadly the following main session categories:

  • Infectious Diseases
  • Autoimmunity
  • Molecular Biology
  • Emerging Technologies Clinical Applications
    Therapeutic Antibodies
  • Cancer
  • Anti-Infective Antibodies
  • Intellectual Property & Legal Issues

For the 2018 and future meetings the scope is being expanded to include sessions on:

  • Formulation
  • Oral Delivery
  • Combination Therapy
  • Validity of Animal Models
  • Peptide Drugs
  • Immunotherapy of Cancer & Autoimmunity

 

Event Details

Monday, October 22, 2018


Pullman Riga Old Town Hotel
Jēkaba iela 24, Centra rajons, Rīga, LV-1050, Latvia

View map
close
Loading...
If you would like to receive related insights and information from Kilpatrick Townsend, please provide your contact details by filling out the form and clicking “Agree.” If you would like to access the PDF only, please click “Download Only.”